Please login or register first to view this content.
Endocrine Disorders Resource Center
Drug Monographs
Click on the subsection below to see prescribing information
NEWS & FEATURES
Higher Levothyroxine Doses Linked to Afib in Older Patients
Insulin Pens Should Be Dispensed in Original Packaging, Says FDA
Ertugliflozin Noninferior for CV Outcomes in T2DM With ASCVD
Once-Weekly Somatrogon Reduces Treatment Burden in Children With GHD
Dapagliflozin Gets Breakthrough Therapy Status for CKD Indication
Is Generic Levothyroxine as Effective as Brand Name for Mild Thyroid Dysfunction?
Alkindi Sprinkle Approved for Pediatric Adrenocortical Insufficiency
Proton Pump Inhibitor Use Linked to Increased Diabetes Risk
Major Adverse CV Event Risk Reduced With SGLT2 Inhibitors
Riomet ER Recalled Due to NDMA Concerns
Metformin May Slow Cognitive Decline in Seniors With T2DM
Thyroid Medication Recalled Due to Subpotent Tablets
Eplerenone May Improve Albumin Excretion in T2D With Acceptable Safety
Synthetic Levothyroxine vs Desiccated Thyroid: TSH Stability Evaluated
Trulicity 3mg, 4.5mg Approved for Type 2 Diabetes
ADA Updates Guideline for Pharmacotherapy of T2DM
FDA Approves Sogroya, a Once-Weekly Growth Hormone Deficiency Therapy
Mycapssa, an Oral Therapy for Acromegaly, Now Available